Today in News History
On July 12, several notable moments in the history of News stand out. In 1863, Albert Calmette, French physician, bacteriologist, and immunologist (died 1933) was born. In 1909, Joe DeRita, American actor (died 1993) was born. In 1923, James E. Gunn, American science fiction author (died 2020) was born. In 1933, Donald E. Westlake, American author and screenwriter (died 2008) was born. In 1976, Anna Friel, English actress was born. In 1977, Brock Lesnar, American mixed martial artist and wrestler was born. In 1996, Jordan Romero, American mountaineer was born. In 2000, Vinícius Júnior, Brazilian footballer was born. In 2006, The 2006 Lebanon War begins. In 2008, Tony Snow, American journalist, 26th White House Press Secretary (born 1955) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
Moderna's Flu Vaccine Moves Closer to FDA Approval
The FDA advisory committee recommended Moderna's flu vaccine for approval. Moderna CEO Stéphane Bancel tells Romaine Bostick and Katie Greifeld he is cautiously optimistic that the agency will follow the guidance. A final decision by the FDA is expected by August 5 which is just in time for the next flu season. He speaks on Bloomberg The Close. (Source: Bloomberg)
Narrative Intelligence Brief
This article was published by Bloomberg, a source frequently categorized with a lean left bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Bloomberg, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from Bloomberg
July 12, 2026
Typhoon Bavi Weakens as Heavy Rain Spreads Across China
July 12, 2026
Korea’s World-Beating Stocks Are Now Trading Cheaper Than Ever
July 11, 2026
Modi Courts Pacific Partners as China, US Reshape Region
July 11, 2026
Modi Courts Indo-Pacific Partners as China, US Reshape Region
July 11, 2026
Warsh and US Inflation Will Set Tone for July Fed Decision
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"cup semifinal"
Argentina beat Switzerland to set up World Cup semifinal against England
[Photo] JUST IN: 🇦🇷 Argentina officially advances to the FIFA World Cup semifinal after defeat [...]
Argentina set up titanic World Cup semifinal against England with extra-time victory over Switzerland after Breel Embolo's embarrassing red card
How other outlets are covering this story
Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
6 sources
Left 50%
Center 33%
Right 17%
Bloomberg
· Jun 25, 2026
Moderna CEO: Cautiously Optimistic on Flu Vaccine Approval
The FDA advisory committee recommended Moderna's flu vaccine for approval. Moderna CEO Stéphane Bancel tells Romaine Bostick and Katie Greifeld he is cautiously optimistic the approval will happen. (Source: Bloomberg)
The Motley Fool
· Jul 3, 2026
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.
BOL News
· Jul 8, 2026
Study finds new Shigella vaccine 89% effective in clinical trial
The findings, published in the journal The Lancet Infectious Diseases, are based on a study involving 73 healthy adults. The post Study finds new Shigella vaccine 89 effective in clinical trial appeared first on BOL News.
The Eastern Herald
· Jun 26, 2026
FDA Panel Backs Moderna mRNA Flu Shot 9-0, Setting Up August Approval Decision
The FDA's Vaccines and Related Biological Products Advisory Committee voted 9-0 on June 18 to recommend Moderna's mRNA flu vaccine for adults 50 and older, the first such endorsement in U.S. history. The agency must now decide by August 5 whether to approve what would be the first licensed mRNA-based seasonal influenza vaccine, even as the Trump administration has canceled 500 million in mRNA research funding.
Medical Daily
· Jun 25, 2026
FDA Panel Backs Moderna's First mRNA Flu Shot — What It Could Mean for Your Fall Vaccine
FDA advisers unanimously backed Moderna's mRNA flu vaccine mFlusiva on June 18. Here's what the 9-0 vote means for fall 2026 vaccination and who it would cover.
NPR Topics: Health
· Jun 27, 2026
If a Lyme disease vaccine gets approved, how would it go over? We asked hunters
Drugmakers are working on a potential new shot to prevent the tick-borne illness. How might it fare in the era of vaccine skepticism?
Topics:
Related coverage for "Moderna's Flu Vaccine Moves Closer to FDA Approval": Bloomberg — Moderna CEO: Cautiously Optimistic on Flu Vaccine Approval. The Motley Fool — Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?. BOL News — Study finds new Shigella vaccine 89% effective in clinical trial. The Eastern Herald — FDA Panel Backs Moderna mRNA Flu Shot 9-0, Setting Up August Approval Decision. Medical Daily — FDA Panel Backs Moderna's First mRNA Flu Shot — What It Could Mean for Your Fall Vaccine. NPR Topics: Health — If a Lyme disease vaccine gets approved, how would it go over? We asked hunters